Cargando…
Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update
In the last few decades, there has been a progressive increase in the prevalence of allergic rhinitis (AR) in China, where it now affects approximately 250 million people. AR prevention and treatment include allergen avoidance, pharmacotherapy, allergen immunotherapy (AIT), and patient education, am...
Ejemplares similares
-
Chinese expert recommendation on transnasal corticosteroid nebulization for the treatment of chronic rhinosinusitis 2021
por: Wang, Chengshuo, et al.
Publicado: (2021) -
Prevalence and trends of sensitisation to aeroallergens in patients with allergic rhinitis in Guangzhou, China: a 10-year retrospective study
por: Wang, Weihao, et al.
Publicado: (2016) -
The Treg/Th17 Imbalance in Patients with Obstructive Sleep Apnoea Syndrome
por: Ye, Jin, et al.
Publicado: (2012) -
Impact of Air Pollutants and Pollen on the Severity of Nonallergic Rhinitis: A Data-Oriented Analysis
por: Huang, Yanran, et al.
Publicado: (2022) -
Gene expression pattern of Treg and TCR Vγ subfamily T cells before and after specific immunotherapy in allergic rhinitis
por: Zheng, Rui, et al.
Publicado: (2014)